Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention

BACKGROUND: The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug–drug interactions with concomitantly used ART. OBJECTIVES: To evaluate the interaction of the antiretroviral drug nevirapine in combination with 4 weeks of daily rifapentine and isoniazid for TB prevent...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Antimicrob Chemother
Hlavní autoři: Podany, A T, Leon-Cruz, J, Hakim, J, Supparatpinyo, K, Omoz-Oarhe, A, Langat, D, Mwelase, N, Kanyama, C, Gupta, A, Benson, C A, Chaisson, R E, Swindells, S, Fletcher, C V
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879140/
https://ncbi.nlm.nih.gov/pubmed/33241266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa470
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky